Search results
Found 16160 matches for
The UK's Medical Research Council (MRC) has confirmed renewal of funding for Dementias Platform UK (DPUK), in partnership with industry and the third sector.
SINAPPS2 Background & PPiP2 Recruitment Training Confirmation
The SINAPPS2 Trial is inviting people with acute psychosis symptom(s) and anti-neuronal membrane antibodies who have been identified through PPiP2 study to consent the trial and help testing the efficacy and safety of immunotherapy for antibody-associated psychosis.